KR20070119451A - Composition of low calori soybean paste salad dressing with antioxidant and antiatherogenic activities and a preparation method thereof - Google Patents
Composition of low calori soybean paste salad dressing with antioxidant and antiatherogenic activities and a preparation method thereof Download PDFInfo
- Publication number
- KR20070119451A KR20070119451A KR1020060054093A KR20060054093A KR20070119451A KR 20070119451 A KR20070119451 A KR 20070119451A KR 1020060054093 A KR1020060054093 A KR 1020060054093A KR 20060054093 A KR20060054093 A KR 20060054093A KR 20070119451 A KR20070119451 A KR 20070119451A
- Authority
- KR
- South Korea
- Prior art keywords
- salad dressing
- dressing
- doenjang
- miso
- salad
- Prior art date
Links
- 235000014438 salad dressings Nutrition 0.000 title claims abstract description 97
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 244000068988 Glycine max Species 0.000 title abstract 7
- 235000010469 Glycine max Nutrition 0.000 title abstract 7
- 230000003078 antioxidant effect Effects 0.000 title description 21
- 239000003963 antioxidant agent Substances 0.000 title description 10
- 230000000489 anti-atherogenic effect Effects 0.000 title 1
- 238000002156 mixing Methods 0.000 claims abstract description 23
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 13
- 235000000346 sugar Nutrition 0.000 claims abstract description 13
- 235000013555 soy sauce Nutrition 0.000 claims abstract description 11
- 239000000052 vinegar Substances 0.000 claims abstract description 11
- 235000021419 vinegar Nutrition 0.000 claims abstract description 11
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 10
- 244000056139 Brassica cretica Species 0.000 claims abstract description 9
- 235000003351 Brassica cretica Nutrition 0.000 claims abstract description 9
- 235000003343 Brassica rupestris Nutrition 0.000 claims abstract description 9
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 9
- 239000006002 Pepper Substances 0.000 claims abstract description 9
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 9
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 9
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 9
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000013345 egg yolk Nutrition 0.000 claims abstract description 9
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 9
- 235000010460 mustard Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 8
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 8
- 244000000231 Sesamum indicum Species 0.000 claims abstract description 5
- 244000291564 Allium cepa Species 0.000 claims abstract 4
- 244000203593 Piper nigrum Species 0.000 claims abstract 4
- 244000294411 Mirabilis expansa Species 0.000 claims description 46
- 235000015429 Mirabilis expansa Nutrition 0.000 claims description 46
- 235000013536 miso Nutrition 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 14
- 239000008162 cooking oil Substances 0.000 claims description 7
- 238000004945 emulsification Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 235000015071 dressings Nutrition 0.000 abstract description 36
- 235000010746 mayonnaise Nutrition 0.000 abstract description 23
- 239000008268 mayonnaise Substances 0.000 abstract description 23
- 239000004615 ingredient Substances 0.000 abstract description 14
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 8
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 8
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 208000008589 Obesity Diseases 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 4
- 201000011510 cancer Diseases 0.000 abstract description 4
- 235000020824 obesity Nutrition 0.000 abstract description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 26
- 235000005911 diet Nutrition 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 239000003925 fat Substances 0.000 description 16
- 230000037213 diet Effects 0.000 description 15
- 235000019197 fats Nutrition 0.000 description 15
- 230000003859 lipid peroxidation Effects 0.000 description 13
- 235000012000 cholesterol Nutrition 0.000 description 11
- 210000005228 liver tissue Anatomy 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 210000005013 brain tissue Anatomy 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 230000005778 DNA damage Effects 0.000 description 8
- 231100000277 DNA damage Toxicity 0.000 description 8
- 108010070675 Glutathione transferase Proteins 0.000 description 8
- 102000005720 Glutathione transferase Human genes 0.000 description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 8
- 241000207961 Sesamum Species 0.000 description 8
- 238000010171 animal model Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 235000018823 dietary intake Nutrition 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- 235000019786 weight gain Nutrition 0.000 description 7
- 230000004584 weight gain Effects 0.000 description 7
- 241000234282 Allium Species 0.000 description 6
- 102000006587 Glutathione peroxidase Human genes 0.000 description 6
- 108700016172 Glutathione peroxidases Proteins 0.000 description 6
- 210000000577 adipose tissue Anatomy 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 241000722363 Piper Species 0.000 description 5
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
- 238000008214 LDL Cholesterol Methods 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- -1 lipid peroxide Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 235000019192 riboflavin Nutrition 0.000 description 4
- 229960002477 riboflavin Drugs 0.000 description 4
- 239000002151 riboflavin Substances 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 240000007817 Olea europaea Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000007912 intraperitoneal administration Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000004792 oxidative damage Effects 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229960003975 potassium Drugs 0.000 description 3
- 210000005084 renal tissue Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000000524 Thiobarbituric Acid Reactive Substance Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000000923 atherogenic effect Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000003927 comet assay Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 235000009200 high fat diet Nutrition 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000002381 testicular Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- XHTYQFMRBQUCPX-UHFFFAOYSA-N 1,1,3,3-tetramethoxypropane Chemical compound COC(OC)CC(OC)OC XHTYQFMRBQUCPX-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010080123 HDL-triglyceride Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- RSYUFYQTACJFML-DZGCQCFKSA-N afzelechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C=C1 RSYUFYQTACJFML-DZGCQCFKSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- UNTBPXHCXVWYOI-UHFFFAOYSA-O azanium;oxido(dioxo)vanadium Chemical compound [NH4+].[O-][V](=O)=O UNTBPXHCXVWYOI-UHFFFAOYSA-O 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 231100000170 comet assay Toxicity 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 229910000009 copper(II) carbonate Inorganic materials 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 239000011646 cupric carbonate Substances 0.000 description 1
- 235000019854 cupric carbonate Nutrition 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- PPNAOCWZXJOHFK-UHFFFAOYSA-N manganese(2+);oxygen(2-) Chemical compound [O-2].[Mn+2] PPNAOCWZXJOHFK-UHFFFAOYSA-N 0.000 description 1
- VASIZKWUTCETSD-UHFFFAOYSA-N manganese(II) oxide Inorganic materials [Mn]=O VASIZKWUTCETSD-UHFFFAOYSA-N 0.000 description 1
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000012033 vegetable salad Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/60—Salad dressings; Mayonnaise; Ketchup
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Seasonings (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
도 1은 된장 샐러드 드레싱의 저장기간에 따른 DPPH 라디칼 소거능의 변화를 보여주는 그래프이다.1 is a graph showing the change of DPPH radical scavenging ability according to the storage period of doenjang salad dressing.
도 2는 된장 샐러드 드레싱의 저장기간에 따른 지질 과산화 억제능의 변화를 보여주는 그래프이다.Figure 2 is a graph showing the change in lipid peroxidation inhibitory ability according to the storage period of doenjang salad dressing.
도 3은 대조군과 된장 샐러드 드레싱군의 실험동물의 평균 체중의 변화를 나타내는 그래프이다.3 is a graph showing the change in the average body weight of the experimental animals of the control group and doenjang salad dressing group.
본 발명은 맛과 기능성이 우수한 된장을 함유한 된장 샐러드 드레싱 조성물 및 이의 제조방법에 관한 것으로 열량이 낮으면서도 영양성분이 풍부하고, 항동맥경화, 항산화성 및 DNA 손상 방지 효과가 높은 된장 샐러드 드레싱용 조성물 및 이의 제조방법에 관한 것이다. The present invention relates to a doenjang salad dressing composition and a method for preparing the doenjang containing miso, which has excellent taste and functionality, and has a low calorie content and rich in nutrients, and has high anti-arteriosclerosis, antioxidant properties, and DNA damage prevention effect. It relates to a composition and a method for preparing the same.
드레싱은 식품을 제조ㆍ가공ㆍ조리함에 있어 식품의 풍미를 돋우기 위한 목 적으로 사용되는 것으로 식용유, 식초 등을 주원료로 하여 식염, 당류, 향신료, 난류 또는 식품첨가물을 가하고 유화시키거나 분리액상으로 제조한 것 또는 이에 과실류, 채소류 등을 가한 것으로 마요네즈, 유화형 드레싱, 분리액상 드레싱, 된장 샐러드 드레싱, 프렌치 드레싱을 말한다. 마요네즈의 상업적 생산은 한국에서 1972년에 기업화된 이후, 소비가 증가되고 있다. 우리나라에서는 마요네즈의 생산이 주종을 이루고 있고, 드레싱의 생산은 부진한 상태에 있지만, 최근 들어 다양한 종류의 드레싱이 시판되고 있다. 미국에서는 마요네즈와 드레싱의 생산비가 45:55로 드레싱이 마요네즈의 소비를 앞지르고 있다. 그 이유로는 마요네즈는 지방함량이 65%로 높기 때문에 지방의 과잉 섭취가 우려되며 이로 인한 총열량의 증가로 여분의 지방을 체내에 축적하게 됨으로써 비만을 야기하고 또한 비만은 만성 퇴행성 질환의 원인이 되기 때문이다(Lands et al. (1992) Am. J. Clin . Nutr . 51: 991-993).Dressing is used to enhance the flavor of food in manufacturing, processing and cooking food. It is made by adding oil, vinegar, vinegar, etc. to salt, sugars, spices, eggs or food additives, and emulsifying or preparing it as a separate liquid. One or the addition of fruits, vegetables, etc. refers to mayonnaise, emulsified dressing, separated liquid dressing, miso salad dressing, and French dressing. Mayonnaise's commercial production has been increasing in consumption since it was industrialized in 1972 in Korea. In Korea, the production of mayonnaise is the dominant, the production of dressings are in a sluggish state, but in recent years a variety of dressings are commercially available. In the United States, the production cost of mayonnaise and dressing is 45:55, and dressing is outpacing consumption. The reason for this is that mayonnaise has a high fat content of 65%, which is concerned about excessive intake of fat, and the increase in total calories causes fat to accumulate in the body, causing obesity and obesity to cause chronic degenerative diseases. (Lands et al. (1992) Am. J. Clin . Nutr . 51: 991-993).
반면, 된장 샐러드 드레싱의 지방함량은 마요네즈에 비하여 매우 적으므로 외국에서는 지방섭취에 민감한 소비자들의 욕구에 부응하여 저열량 마요네즈나 다양한 된장 샐러드 드레싱이 개발되어 시판되고 있다(Chitalt et al. (1992) J. Food Sci . 57: 200-202).On the other hand, since the fat content of doenjang salad dressing is much lower than that of mayonnaise, low calorie mayonnaise or various miso salad dressings have been developed and marketed in response to the needs of consumers who are sensitive to fat intake (Chitalt et al. (1992) J. Food Sci . 57: 200-202).
최근 우리나라도 국민 소득이 증가되고 식생활이 서구화되면서 동물성 지방의 섭취가 늘어 성인병의 유발이 증가되고 있는 시점에서 지방함량이 마요네즈보다 적은 샐러드 드레싱류를 더 선호할 것으로 전망되나 현재까지 마요네즈에 관한 연구에 비해 샐러드 드레싱에 관한 연구는 부족한 실정이다. 최근 드레싱류가 개발되어 시판되고 있기는 하나 주로 서구의 드레싱으로 동양인의 입맛에 맞으면서 기능 성 물질이 풍부한 된장, 참깨, 간장 등을 사용하여 제조한 된장드레싱에 관한 연구는 미미한 실정이다.Recently, Korea is expected to prefer salad dressings with less fat than mayonnaise at the point of increasing the national income and westernized diet, which leads to increased intake of animal fat and increased incidence of adult diseases. Compared to the salad dressing research is insufficient. Although dressings have been developed and marketed recently, studies on miso dressing made mainly of Western dressings made with miso, sesame, and soy sauce, which are rich in functional substances and suited to Asian tastes, are insignificant.
본 발명은 상기 종래기술의 문제점을 해결하기 위한 것으로 마요네즈에 비해 열량이 적은 된장을 샐러드 드레싱에 첨가함으로써 된장의 인체에 유의한 영양성분과 유용한 생리활성을 갖는 된장 샐러드 드레싱 조성물 및 그의 제조방법을 제공하고자 하는 것을 목적으로 한다.The present invention is to solve the problems of the prior art to provide a doenjang salad dressing composition having a significant nutritional value and useful physiological activity to the human body of doenjang by adding to the salad dressing less calories than mayonnaise and a method of manufacturing the same It is intended to be.
이하, 본 발명의 구성 및 작용을 설명한다.Hereinafter, the configuration and operation of the present invention.
본 발명은 맛과 기능성이 우수한 된장을 함유한 된장 샐러드 드레싱을 제공한다.The present invention provides a miso salad dressing containing miso excellent in taste and functionality.
본 발명의 된장을 함유한 된장 샐러드 드레싱 조성물은 식용유 27~28%, 난황 0.01~0.02%, 겨자 0.001~0.002%, 양파 5~6%, 된장 10.5~11.5%, 설탕 16~17%, 간장 1.6~1.7%, 식초 21.5~22.5%, 참깨 8~9%, 후추 0.5~0.6% 및 소금 1~1.5%로 전체가 100%가 되도록 물을 함유하는 것을 특징으로 한다.Miso salad dressing composition containing miso of the present invention is cooking oil 27 ~ 28%, egg yolk 0.01 ~ 0.02%, mustard 0.001 ~ 0.002%,
된장 샐러드 드레싱의 재료로서 항산화성에 초점을 맞추어 기능성을 부여하고 동양인의 입맛에 맞는 재료 중에서 된장, 간장, 참깨를 선정하였다. 예비 실험을 통해 이들 재료의 배합 비율을 달리하면서 된장 샐러드 드레싱을 제조 후 관능검사를 통해 첨가비율을 결정하였다. Doenjang, soy sauce, and sesame seeds were selected as ingredients of doenjang salad dressing, focusing on antioxidant properties, and giving functionality to Asian tastes. The preliminary experiments were performed to prepare the miso salad dressing while varying the mixing ratio of these ingredients, and then the addition ratio was determined by sensory test.
상기의 된장 샐러드 드레싱 조성물의 제조방법은 난황, 겨자, 소금 및 후추 를 배합비에 따라 혼합하는 제1단계; 상기 제1단계에 의한 혼합물을 믹싱볼에 넣고 배합비의 식초를 투입하여 교반하는 제2단계; 상기 제2단계에 의한 혼합물에 식용유를 서서히 주입하면서 계속 교반하여 유화시키고, 유화가 끝난 후에 다시 3~5분간 더 교반하여 드레싱 재료를 제조하는 제3단계; 배합비에 따른 된장, 간장, 양파, 참깨, 물 및 설탕을 별도로 혼합하는 제4단계; 및 상기 제3단계의 혼합물에 제4단계의 혼합물을 소량씩 첨가하면서 혼합하는 단계로 구성되는 것을 특징으로 한다. 된장 샐러드 드레싱은 상기의 배합방법에 의해 혼합할 경우 유화가 가장 효율적으로 이루어지며, 모든 재료를 한꺼번에 혼합되면 각 조성물간의 유화가 효율적이지 못하여 분리된다.Method for producing the miso salad dressing composition of the first step of mixing egg yolk, mustard, salt and pepper according to the mixing ratio; A second step of putting the mixture according to the first step into a mixing bowl and adding vinegar in a mixing ratio to stir; A third step of preparing the dressing material by continuously stirring and emulsifying the cooking oil into the mixture according to the second step and further stirring for 3 to 5 minutes after the completion of the emulsification; A fourth step of separately mixing miso, soy sauce, onion, sesame seeds, water and sugar according to the blending ratio; And mixing the mixture of the fourth step with a small amount of the mixture of the third step. Doenjang salad dressing is the most efficient emulsification when mixed by the above mixing method, and when all the ingredients are mixed at once emulsification between each composition is not efficient and separated.
된장 샐러드 드레싱의 in-vitro 항산화성을 DPPH 라디칼 소거능과 지질 과산화 억제능의 IC50 값으로 측정한 결과, 대조구(시판마요네즈)보다 항산화성이 높은 것을 확인할 수 있었다. The in-vitro antioxidant activity of doenjang salad dressings was measured by the IC 50 values of DPPH radical scavenging activity and lipid peroxidation inhibitory activity. As a result, the antioxidant activity was higher than that of the control (commercial mayonnaise).
In-vitro에서 확인된 항산화성이 in- vivo에서도 유효한지 검증하기 위하여 체중 20-25g 정도의 생후 4주령된 ICR mice(수컷)를 대상으로 대조군과 대조군에 된장 샐러드 드레싱을 함께 급여한 된장 샐러드 드레싱군으로 나누어 동물실험을 실시하였다. In-vitro with the anti-in- weight to about 20-25g in vivo to valid verification of the age of 4 week-old ICR mice by miso salad dressing with miso salad dressing salary in the control group and the control group targets (male) OK Animal experiments were conducted in groups.
된장 샐러드 드레싱을 일반 식이에 첨가한 군의 식이 섭취량, 체중증가량은 대조군과 유의한 차이가 인정되지 않아 된장 샐러드 드레싱의 섭취로 인한 체중증가는 없었다. 그러나 총체지방무게는 대조군에 비하여 유의적으로 적었으며 특히 부위별 지방조직중 복부와 고환주위의 지방축적량이 적어 성인병예방에 좋은 효과가 있는 것으로 판단된다. 한편, 각 장기(간, 심장, 뇌, 신장) 조직의 무게는 대조군과 된장샐러드 드레싱을 첨가한 군간에 유의한 차이가 없어서 부작용이나 독성이 나타나지 않았다. 혈장 중의 지질조성중 총 중성지질, 총 콜레스테롤, LDL cholesterol 함량이 대조군에 비하여 된장 샐러드 드레싱 군간이 낮아졌으며 또한 동맥경화위험지수도 낮아져 동맥경화 예방에 좋은 효과를 나타내었다. 본 실험에서는 식사 중의 지방함량이 40%, 콜레스테롤이 1%로 고지방 고콜레스테롤식이를 급여하였기 때문에 체중 증가 및 체지방(복부 등) 증가 현상뿐만 아니라 동맥경화 등의 원인이 되는 혈중 지질농도증가, 혈중 콜레스테롤 증가 등의 현상이 나타나므로 건강에 좋지 않은 영향을 준다. 그러나 된장 샐러드 드레싱을 식이에 첨가하여 급여시킨 된장 샐러드 드레싱의 군에서 대조군에 비해 총 체지방 함량, 혈중 콜레스테롤, 혈중 지질 함량을 억제함으로써 성인병에 좋은 효과가 있음을 보여준다.The dietary intake and weight gain of the doenjang salad dressings added to the general diet were not significantly different from the control group. However, the total fat weight was significantly lower than that of the control group, and especially the amount of fat accumulation around the abdomen and testicles among the adipose tissues of each region was considered to be a good effect in preventing adult diseases. On the other hand, the weight of each organ (liver, heart, brain, kidney) tissue was not significantly different between the control group and the doenjang salad dressing, there was no side effect or toxicity. The total triglyceride, total cholesterol and LDL cholesterol contents in the plasma lipid composition were lower in the doenjang salad dressing group and the atherosclerotic risk index was lower than that of the control group. In this experiment, a high-fat, high-cholesterol diet was fed with 40% fat and 1% cholesterol, so not only weight gain and body fat (abdominal, etc.) but also blood lipid concentrations and blood cholesterol, which cause arteriosclerosis, were observed. Symptoms such as increases appear to have an adverse effect on health. However, in the group of doenjang salad dressing supplemented with dietary doenjang salad dressing, the total body fat content, blood cholesterol, and blood lipid content are suppressed compared to the control group, which shows a good effect on adult diseases.
샐러드 드레싱의 항산화성은 간조직 및 뇌조직내 항산화 효소 활성도, 조직 내 지질의 과산화 정도로 측정하였다.Antioxidant activity of salad dressings was measured by antioxidant enzyme activity in liver and brain tissues and the degree of peroxidation of lipids in tissues.
항산화 효소 활성은 간 및 뇌조직의 GP(Glutathione peroxidase), GST(glutathione S-transferase)활성도를 측정하여 비교하였다. 간 및 뇌 조직에서의 항산화효소인 글루타치온 페록시다제(Glutathione peroxidase) 활성을 유의적으로 높여주었으며, 항발암해독효소인 GST활성을 대조군에 비하여 간조직에서는 1.75배 뇌조직에서는 1.45배 증가시켰다. Antioxidant enzyme activity was compared by measuring GP (glutathione peroxidase) and GST (glutathione S-transferase) activity in liver and brain tissue. The activity of glutathione peroxidase, an antioxidant enzyme in liver and brain tissues, was significantly increased, and the anti-cancer detoxifying enzyme, GST activity, was 1.75 times higher in liver tissues and 1.45 times higher in brain tissues than in controls.
혈액, 간, 심장, 신장, 뇌조직에서의 지질 과산화 정도를 TBARS로 분석하였 을 때 된장샐러드 드레싱 군의 TBARS값이 대조군에 비하여 각각 유의적으로 낮게 나타나, 지질 과산화가 억제됨을 확인할 수 있었다. 이는 대조군에 비하여 지질 과산화가 20-35%까지 억제된 것으로 된장 샐러드 드레싱에 함유된 된장, 참깨, 양파 등에 기인된 것이다. 간조직에서 지질의 과산화는 라디칼에 의한 membrane의 손상을 초래하여 산화적 손상에 의해 유발되는 노화, 동맥경화, 암 등 거의 모든 질병의 원인이 되므로 드레싱 섭취로 인해 간 조직 membrane내 지질과산화가 현저히 감소하였으므로 상기의 질환에 효과가 있을 것으로 기대된다. When TBARS was analyzed for lipid peroxidation in blood, liver, heart, kidney, and brain tissues, the TBARS values of the doenjang salad dressing group were significantly lower than those of the control group, indicating that lipid peroxidation was inhibited. This is due to the suppression of lipid peroxidation by 20-35% compared to the control group, due to the miso, sesame, onion, etc. contained in the miso salad dressing. Lipid peroxidation in liver tissue leads to radical damage to the membrane, which causes almost all diseases such as aging, arteriosclerosis, and cancer caused by oxidative damage. It is expected to be effective in the above diseases.
혈액 중 임파구의 DNA 손상정도를 comet assay로 분석한 결과, 샐러드 드레싱군이 대조군에 비하여 tail DNA(%), tail length 및 tail moment가 모두 유의적으로 높아 샐러드 드레싱이 혈액중의 DNA를 효과적으로 보호하는 것을 확인하였다. 혈액 임파구의 DNA 손상을 방지하는 효과가 있으므로, 산화적 손상에 의해 유발되는 노화를 비롯한 각종 질병 즉, 동맥경화, 암 등의 예방에 효과가 있을 것으로 기대된다. As a result of analyzing the DNA damage of lymphocytes in blood by the comet assay, the salad dressing group showed significantly higher tail DNA (%), tail length, and tail moment compared to the control group. It was confirmed. Since it is effective in preventing DNA damage of blood lymphocytes, it is expected to be effective in preventing various diseases including aging caused by oxidative damage, namely arteriosclerosis and cancer.
이하, 본 발명을 실시예 에 대해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, embodiments of the present invention will be described in detail. However, the following examples are merely to illustrate the invention, but the content of the present invention is not limited to the following examples.
실시예Example 1 : 된장샐러드 드레싱의 최적 배합비율 선정 1: Selecting the optimal blending ratio of miso salad dressing
실험재료Experimental material
마요네즈 제조에 필요한 식초(청정원), 옥수수 식용유(청정원), 겨자(청정 원), 후추(오뚜기) 및 달걀은 시중 슈퍼마켓에서 구입하여 냉장보관(5℃)하며 사용하였으며 난황은 달걀에서 분리하여 사용하였다. 된장(해찬들), 간장(샘표), 설탕(청정원), 볶은 참깨, 양파 역시 시중의 슈퍼마켓에서 구입하여 사용하였다.The vinegar (clean garden), corn cooking oil (clean garden), mustard (clean garden), pepper (Ottogi) and eggs needed for the manufacture of mayonnaise were purchased at commercial supermarkets and stored in the refrigerator (5 ℃), and egg yolks were separated from eggs. . Doenjang (Haechansul), soy sauce (Sempyo), sugar (Cheongwon), roasted sesame seeds, onions were also purchased at the supermarket.
하기 실시예의 모든 실험은 3회 반복하였으며 실험 결과는 SAS program 중에서 분산 분석(ANOVA)을 실시하여 유의성이 있는 경우에 Duncan의 다중범위검정(Duncan‘s multiple range test)을 실시하였다(SAS Institute, Inc. 1988, Steel & Torrie 1960).All experiments in the following examples were repeated three times, and the results of the experiments were performed by ANOVA in the SAS program, and Duncan's multiple range test was performed when significant (SAS Institute, Inc.). 1988, Steel & Torrie 1960).
1) 된장 샐러드 드레싱의 제조1) Preparation of Miso Salad Dressing
예비 관능 검사 실험을 통해 표 1의 배합비(중량비)로 하기 방법에 따라 된장 샐러드 드레싱을 제조하였다.Doenjang salad dressing was prepared according to the following method by the compounding ratio (weight ratio) of Table 1 through a preliminary sensory test.
먼저 난황, 겨자, 소금, 후추를 배합비에 따라 믹싱볼에 넣고 전기비터(HM-213: Main Power Electrical Factory Ltd)로 10초간 교반하였다. 여기에 배합비의 식초를 넣고 다시 10초간 교반한 후 식용유를 서서히 주입하면서 계속 교반하여 10분간 유화시켰다. 유화가 끝난 후에 다시 3분간 더 교반하여 드레싱 재료로 사용하였다.First, egg yolk, mustard, salt, and pepper were added to the mixing bowl according to the mixing ratio and stirred for 10 seconds with an electric beater (HM-213: Main Power Electrical Factory Ltd). After adding the vinegar in the blending ratio to the mixture for 10 seconds, the mixture was continuously stirred while injecting cooking oil and emulsified for 10 minutes. After emulsification, the mixture was further stirred for 3 minutes to use as a dressing material.
별도로, 배합비에 따른 된장, 간장, 양파, 참깨, 물 및 설탕을 Osterizer blender(SQ-205, (주)일진가전)에서 교반하여 혼합한 후 상기의 방법으로 제조한 드레싱에 소량씩 첨가하면서 전기비터로 교반하여 혼합하였다.Separately, mix the miso, soy sauce, onion, sesame, water and sugar according to the mixing ratio by stirring in an Osterizer blender (SQ-205, ILJIN Electric Appliance), and then add a small amount to the dressing prepared by the above method. Stirred and mixed.
2) 관능검사2) Sensory test
충남대학교 식품영양학과 학생 90명을 대상으로 상기의 된장 샐러드 드레싱과 대조군으로 마요네즈를 드레싱으로 하여 채소 샐러드와 함께 제공하여, 외관, 향, 맛, 조직감 및 전반적인 기호도를 5점 척도법으로 평가하고 그 결과를 표 2에 도시하였다.A total of 90 students from the Department of Food and Nutrition, Chungnam National University, served with vegetable salad with the doenjang salad dressing and mayonnaise as a dressing, and evaluated the appearance, aroma, taste, texture, and overall acceptability on a five-point scale. Is shown in Table 2.
외관(색)에 대한 점수는 대조군이 2.1점이었고, 향에 대한 기호도 점수는 대조군은 1.3점이었고, 맛에 대한 기호도 점수는 대조군이 2.2점이었다. 조직감에 대한 기호도 점수는 대조군은 3.0점이었다. 반면, 된장 샐러드 드레싱의 외관(색)에 대한 점수는 3.6점, 향에 대한 점수는 3.7점, 맛에 대한 기호도 점수는 3.8점, 조직감에 대한 점수는 3.5점으로 대조군보다 점수가 높았다(p<0.05).The score for appearance (color) was 2.1 for the control group, the preference score for the flavor was 1.3 for the control group, and the control score for the taste was 2.2 for the control group. The preference score for texture was 3.0 in the control group. On the other hand, score of 3.6 for the appearance (color) of doenjang salad dressing, 3.7 for flavor, 3.8 for taste, and 3.5 for texture were higher than the control group ( p < 0.05).
전반적인 기호도 점수는 대조군이 2.5점에 비해, 된장 샐러드 드레싱의 기호도 점수가 가장 높았다(p<0.05).Overall palatability score was highest in the control group compared with 2.5 points ( p <0.05).
실시예Example 2 : 된장 샐러드 드레싱의 영양성분 분석 2: Nutritional Analysis of Doenjang Salad Dressing
실시예 1에서 제조한 된장 샐러드 드레싱 100g 중 영양성분을 AOAC법(1990)에 따라 분석하였다.Nutrients in 100 g of miso salad dressing prepared in Example 1 were analyzed according to the AOAC method (1990).
즉, 수분은 상압 가열 건조법, 조단백질은 micro-Kjeldahl법, 조지방은 Soxhlet 추출법, 회분은 직접 회화법으로 각각 측정하였고, 조섬유는 Henneberg-Stohmann법을 개량한 방법으로 측정하였으며, 당질은 시료 100g 중에서 수분, 단백질, 지질, 조섬유, 회분 함량을 감한 값으로 하였고, 에너지는 가식부 100g 당 분석된 단백질, 당질, 지방의 g수에, FAO/WHO 에너지 환산계수를 적용하여 산출하였다. 무기질 성분은 시료를 microwave 시료전처리기(MLS1200, Milestone, Italy)로 습식분해한후 Ca, Fe, Mg, K, Na, Zn은 원자흡광광도계(Z6100, Hitachi, Japan)로, P은 ammonium vanadate 발색법으로 측정하였다.Moisture was measured by atmospheric heating and drying method, crude protein was measured by micro-Kjeldahl method, crude fat was measured by Soxhlet extraction method and ash by direct incineration method, and crude fiber was measured by improved method of Henneberg-Stohmann method. , Protein, lipid, crude fiber, and ash content were subtracted, and energy was calculated by applying the FAO / WHO energy conversion factor to the number of proteins, sugars, and fats analyzed per 100 g of edible portion. Inorganic components are wet decomposition of the sample with microwave sample pretreatment (MLS1200, Milestone, Italy), Ca, Fe, Mg, K, Na, Zn are atomic absorption spectrophotometer (Z6100, Hitachi, Japan), P is ammonium vanadate Measured by the method.
가. 일반성분end. General ingredient
제조된 된장샐러드 드레싱의 일반성분을 분석한 결과는 표 3과 같았다. 일반성분은 된장드레싱이 단백질, 섬유소 및 회분 함량에서 약간 높은 값을 보였는데, 사우전드 아일랜드, 이탈리안 및 프렌치 등 기 보고된 샐러드드레싱의 일반성분과는 단백질, 당질 및 지질 함량에서 차이를 보였다(식품성분표 2001). 단백질의 경우 사우전드 아일랜드드레싱 등이 100 g 당 1 g 내외인 반면 새로 개발된 샐러드드레싱은 단백질 함량이 5배 이상 함유되어 있으며, 당질 함량은 2배, 섬유소 함량은 약 10배 이상 많이 함유된 것으로 나타났다. 이와는 달리 지질 함량에서는 기 보고된 샐러드드레싱이 100 g 당 41~48 g의 지질을 함유한 반면 개발된 드레싱은 100 g 당 33 g 수준으로 10% 정도 낮았으며, 총 열량의 경우도 기존의 샐러드드레싱(430~480 g/100g)에 비하여 100 g당 50~100 kcal 정도 낮은 것으로 분석되었다. 결과적으로 본 발명에서 제조한 샐러드드레싱은 기존의 샐러드드레싱에 비하여 섬유소 함량이 많고, 지방 함량은 적어서 저칼로리 다이어트용 샐러드드레싱으로 적절할 것으로 생각되었다. The results of analyzing the general ingredients of the prepared doenjang salad dressing are shown in Table 3. Doenjang dressing showed a slightly higher value in protein, fiber, and ash content than the other ingredients of salad dressing, such as Thousand Island, Italian and French. Ingredient Table 2001). In the case of protein, Thousand Island Dressing, etc. is about 1g per 100g, while the newly developed salad dressing contains more than 5 times protein, 2 times more sugar, and more than 10 times more fiber. appear. On the other hand, in the lipid content, the previously reported salad dressing contained 41-48 g of lipid per 100 g, while the developed dressing was about 10% lower at 33 g per 100 g. It was analyzed that 50-100 kcal per 100 g was lower than (430-480 g / 100g). As a result, the salad dressing prepared in the present invention was considered to be suitable as a salad dressing for a low calorie diet because of a high fiber content and a low fat content as compared to the conventional salad dressing.
나. 무기질 성분 I. Mineral
된장샐러드드레싱의 무기질 성분은 표 4와 같았다. 새로 개발된 된장드레싱의 무기질 성분은 사우전드 아일랜드, 이탈리안 및 프렌치 등 기 보고된 샐러드드레싱의 무기질 성분과는 큰 차이를 보였는데, 칼슘 함량은 약 10배 정도 높았고, 인과 칼륨함량도 2~3배 정도 많이 함유하는 것으로 나타났다. 나트륨 함량의 경우에는 프렌치드레싱(1370 mg/100g)보다는 낮았으나, 사우전드 아일랜드드레싱(761 g/100g), 이탈리안드레싱(87 g/100g)과는 유사한 수준으로 분석되었다(식품성분표 2001). 새로 개발된 된장샐러드드레싱은 기존의 샐러드드레싱에 비하여 칼슘, 칼륨 등 풍부한 무기성분과 다수의 생리활성 물질을 함유한 된장을 활용한 측면에서 기능성 샐러드드레싱으로 가치가 있을 것으로 판단되었다.The mineral components of doenjang salad dressings are shown in Table 4. The mineral content of the newly developed doenjang dressing was significantly different from the minerals of salad dressings, such as Thousand Island, Italian and French, which were about 10 times higher in calcium and 2 to 3 times higher in phosphorus and potassium. It was found to contain much. The sodium content was lower than French dressing (1370 mg / 100g), but was analyzed at levels similar to Thousand Island Dressing (761 g / 100g) and Italian Dressing (87 g / 100g) (Food Ingredients 2001). The newly developed doenjang salad dressing is considered to be valuable as a functional salad dressing in terms of the use of doenjang which contains abundant inorganic ingredients such as calcium and potassium and many bioactive substances, compared to the existing salad dressing.
다. 비타민 성분 All. Vitamin ingredients
된장샐러드드레싱의 비타민 함량을 분석한 결과는 표 5와 같았다. 된장 샐러드드레싱의 비타민 중, 100 g당 베타카로틴 함량은 200 ㎍ 수준이었고, 티아민과 리보플라빈은 0.13~0.18 mg, 나이아신의 경우는 100 g당 0.4 mg이었으며, 아스코르빈산은 검출되지 않았다. 이러한 결과는 사우전드 아일랜드드레싱에 비하여 베타카로틴 함량은 2배 수준이며, 티아민과 리보플라빈 및 나이아신은 각각 2~6배 정도 많이 함유하는 결과로 기존의 샐러드드레싱보다 다량의 비타민을 함유하는 것을 나타낸다(식품성분표, 2001). 결과적으로 새로 개발된 된장샐러드드레싱은 기존의 샐러드드레싱보다 다량의 비타민을 함유하여 영양학적으로 보다 우수하며, 기존의 샐러드드레싱에 비하여 건강유지에 보다 효과적으로 기여할 것으로 생각되었다. The results of analyzing the vitamin content of doenjang salad dressing are shown in Table 5. Among the vitamins of doenjang salad dressing, beta-carotene content per 100 g level was 200 μg, thiamin and riboflavin were 0.13-0.18 mg, niacin 0.4 mg per 100 g, no ascorbic acid was detected. These results indicate that the beta-carotene content is two times higher than that of Thousand Island Dressing, and that thiamine, riboflavin, and niacin are two to six times higher than each other. Ingredient list, 2001). As a result, the newly developed doenjang salad dressing contains more vitamins than the conventional salad dressing, which is nutritionally superior, and is expected to contribute to maintaining health more effectively than the existing salad dressing.
실시예Example 3 : 된장 샐러드 드레싱의 3: of miso salad dressing in-vitro in-vitro 항산화성Antioxidant
실시예 1에서 제조한 된장 샐러드 드레싱의 항산화성을 DPPH(1,1-diphenyl-2-picrylhydrazyl) 라디칼 소거능과 TBARS(2-thiobarbituric acid reactive substances) 함량의 IC50(50% 저해시키는데 필요한 농도)값으로 측정하였다.The antioxidant properties of the doenjang salad dressing prepared in Example 1 were IC 50 (concentration required for 50% inhibition) of DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging ability and 2-thiobarbituric acid reactive substances (TBARS) content. Measured by.
(1) DPPH 라디칼 소거능(1) DPPH radical scavenging activity
된장 샐러드 드레싱 10g에 각각 2배의 메탄올을 넣고 10분간 blending한 후 원심분리(3,000 rpm 20 min)하였다. 각각의 상층액을 취해서 1.5×10-4 M 농도의 DPPH 용액에 30분간 반응시킨 후 515nm에서 흡광도를 분광광도계(352, Pharmacia Co.)로 측정하여 IC50값을 표 6에 나타내었다.Two times methanol was added to 10 g of doenjang salad dressing and blended for 10 minutes, followed by centrifugation (3,000
DPPH 라디칼 소거능의 IC50값으로 측정한 된장 샐러드 드레싱의 항산화성은 대조군이 58.2 mg/mL이었으며, 된장샐러드드레싱의 IC50 값은 유의적으로 감소하였다(p<0.05). 또한 마요네즈의 IC50값은 174.91 mg/mL로 기능성 재료를 첨가하지 않은 군에 비하여 1.5배 가량 높아 항산화성이 매우 낮아 본 발명의 된장 샐러드 드레싱은 항산화능이 높은 기능성 된장 샐러드 드레싱으로 마요네즈를 대체하여 이용할 수 있음을 확인할 수 있었다.Antioxidant activity of doenjang salad dressing measured by IC 50 value of DPPH radical scavenging activity was 58.2 mg / mL in the control group, and IC 50 value of doenjang salad dressing was significantly decreased ( p <0.05). In addition, the IC 50 value of mayonnaise is 174.91 mg / mL, which is about 1.5 times higher than the group without the addition of functional ingredients, and thus has very low antioxidant activity. The miso salad dressing of the present invention can be used to replace mayonnaise with a functional antioxidant miso salad dressing. Could confirm.
(2) 지질 과산화 억제능(2) lipid peroxidation inhibitory ability
지질 과산화 억제능은 TBARS법(2-thiobarbituric acid reactive substances)으로 측정하였다. 드레싱 0.5g에 0.75% thiobarbituric acid(TBA)/15% trichloroacetic acid(TCA)용액 2mL을 혼합한 후 90℃에서 15분간 가열하고 10분간 얼음물로 냉각한 후 3,000rpm에서 20min분간 원심분리하였다. 상층액을 분리하여 533nm에서 흡광도를 측정하였다. 표준곡선은 malondialdehyde를 사용하였으며 이때 표준곡선의 식은 Y=245.25X+0.1071 (R 2=0.9896)이었다. 이때 얻어진 결과는 ㎍ malondialdehyde/mL sample로 표시하였다.Lipid peroxidation inhibitory activity was measured by TBARS (2-thiobarbituric acid reactive substances). 0.75% thiobarbituric acid (TBA) / 15% trichloroacetic acid (TCA) solution in 0.5 g of dressing After mixing 2mL and heated for 15 minutes at 90 ℃, cooled with ice water for 10 minutes and centrifuged for 20 minutes at 3,000rpm. The supernatant was separated and the absorbance was measured at 533 nm. The standard curve was malondialdehyde, where the equation was Y = 245.25X + 0.1071 ( R 2 = 0.9896). The obtained results are expressed in μg malondialdehyde / mL sample.
된장 샐러드 드레싱의 지질 과산화 억제 정도는 상기 표 6에 DPPH 소거능과 함께 기재하였다. 대조군(시판마요네즈)의 IC50(지질과산화를 50% 저해시키는데 필요한 농도)값은 7.60 ㎍/mL이었으며 된장샐러드드레싱은 4.76 ㎍/mL로 IC50 값은 유의적으로 감소하여(p<0.05), 지질 과산화가 효과적으로 억제됨을 알 수 있었다. 본 발명의 된장 샐러드 드레싱이 높은 지질 과산화 억제 효과를 나타내는 것은 , 참깨 등에 함유된 polyphenol이나 리그난 등이 유지의 산패를 억제해 주기 때문이다.The degree of lipid peroxidation inhibition of doenjang salad dressing is described in Table 6 together with DPPH scavenging ability. The IC 50 (concentration required to inhibit 50% lipid peroxidation) value of the control group (commercial mayonnaise) was 7.60 μg / mL, and the doenjang salad dressing was 4.76 μg / mL, which significantly decreased the IC 50 value ( p <0.05), Lipid peroxidation was effectively inhibited. The miso salad dressing of the present invention exhibits a high lipid peroxidation inhibitory effect because polyphenols and lignans contained in sesame seeds and the like suppress the rancidity of fats and oils.
실시예Example 4 : 된장 샐러드 드레싱의 4: miso salad dressing in-in- vivovivo 동물실험을 통한 항동맥경화 및 항산화성 조사Investigation of anti-arteriosclerosis and antioxidant activity through animal experiment
1) 된장 샐러드 드레싱의 제조1) Preparation of Miso Salad Dressing
실시예 1에서 제조한 된장 샐러드 드레싱을 제조한 후 동결건조 후 냉동보관(-70℃)하면서 사료제조에 사용하였다. Doenjang salad dressing prepared in Example 1 was prepared and then lyophilized and used for feed preparation while being kept frozen (-70 ° C).
2) 실험동물2) Experimental Animal
체중 20-25g 정도의 생후 4주령된 ICR mice(수컷) 20마리를 구입하여 실험 시작 전 고형 배합사료(삼양 사료 주식회사)로 1 주일간 적응시켰다. 적응기간이 끝난 실험동물은 체중에 따른 난괴법(randomized complete block design)으로 각 군당 10마리씩 2군으로 나누어 12주 동안 사육하였다. 사육실의 온도는 23±2℃, 습도는 50~60%로 조절하였고, 매일 광주기 및 암주기를 각각 12시간이 되도록 조절하였다. 실험동물은 두 마리씩 stainless steel cage에서 사육하였고, 실험식이와 먹는 물은 24시간 동안 자유 급식으로 공급하였으며, 무기질의 오염 방지를 위해서 사육실에 필요한 모든 기구는 0.4%의 EDTA로 씻은 후 탈이온 증류수로 헹구어 사용하였다.Twenty four-week-old ICR mice (males) weighing 20-25 g were purchased and adapted to solid feed (Samyang Feed Co., Ltd.) for one week before the start of the experiment. After the adaptation period, the animals were reared for 12 weeks by dividing the animals into two groups of 10 animals in each group by a randomized complete block design. The temperature of the nursery was adjusted to 23 ± 2 ℃, humidity was 50 ~ 60%, daily photoperiod and dark cycle was adjusted to 12 hours each. Two experimental animals were raised in stainless steel cages, and the experimental diet and drinking water were fed freely for 24 hours. Rinse was used.
모든 실험 결과는 실험 동물 10 마리의 평균치±표준편차로 표시하였으며, 유의성 검증은 SPSS(Statistical Package for Social Sciences. SPSS Inc., Chicago IL, USA) software package 프로그램을 이용하여 Student t-test에 의하여 각 실험군의 평균치간 유의성을 검정하였다.All experimental results were expressed as mean ± standard deviation of 10 experimental animals, and significance test was performed by Student t-test using the statistical package for social sciences.SPSS Inc., Chicago IL, USA The significance between the mean values of the experimental groups was tested.
3) 식이 조성3) dietary composition
사료 1Kg 중 식이 성분의 함량(g)을 표 7에 기재하였다. 실험식이는 대조군은 총 식이 무게의 5%(열량의 11.7%)를 옥수수유(동방유량)와 라드(동광농산)로 공급하였고, 드레싱군은 총 식이무게의 15%를 첨가하였으며 드레싱에 첨가된 설탕의 함량을 대조군에서 제한 후 대조군과 드레싱군의 총열량은 동일하게 맞추어 조절하였다. 각 군의 식이는 매주 한 번씩 만들어 사용하였고 지방의 산패를 방지하기 위해 -70℃ 냉동고에 보관하면서 정해진 시간에 매일 일정량을 급여하였다.Table 7 shows the content (g) of the dietary component in 1 Kg of the feed. In the experimental diet, the control group supplied 5% of the total diet weight (11.7% of calories) as corn oil (oriental flow) and lard (donggwang agricultural), and the dressing group added 15% of the total dietary weight. After limiting the content of sugar in the control group, the total calorific value of the control group and the dressing group was adjusted to be the same. Each group's diet was made once a week and used to feed a certain amount every day at a fixed time while stored in a -70 ℃ freezer to prevent fat rancidity.
4) 식이 섭취량, 체중 증가량, 식이 효율 및 4) dietary intake, weight gain, dietary efficiency and 분변의Fecal 양 amount
실험 동물의 식이 섭취량은 매일 오후 2시경에 측정하였으며, 체중 측정은 갑작스런 체중 증가를 막기 위해 1시간 전에 식이 공급을 중단한 후 매주 일정한 시간에 한 번씩 측정하였다. 분변의 양은 식이 마지막 주, 즉 8주에 3일간 채취하여 동결 건조 후 무게를 측정하였다. 식이 효율(food efficiency ratio, FER)은 총 체중 증가량을 같은 기간 동안의 총 식이 섭취량으로 나눈 값으로 산출하여 식이섭취량, 체중 증가량, 분변량과 함께 표 8에 기재하였다. 체중 변화는 도 3에 도시하였다. 도 3에서 HFC는 대조군을 HFD는 된장 샐러드 드레싱군을 의미하며, 모두 고콜레스테롤 식이를 하였다.The dietary intake of the test animals was measured at about 2 pm every day, and the weight was measured once a week at regular intervals after the feeding was stopped an hour before to prevent sudden weight gain. The amount of feces was collected for 3 days at the end of the diet, that is, 8 weeks, and weighed after freeze-drying. The food efficiency ratio (FER) is calculated by dividing the total weight gain divided by the total dietary intake during the same period, and is shown in Table 8 together with the dietary intake, weight gain, and feces. Body weight change is shown in FIG. 3. In Figure 3, HFC refers to the control group, HFD means doenjang salad dressing group, all had a high cholesterol diet.
표 8에서 보는 바와 같이 식이섭취량은 대조군과 된장 샐러드 드레싱군 사이에 유의적인 차이가 없었다. 분변의 양 또한 된장 샐러드 드레싱군이 많았지만 유의적인 차이는 인정되지 않았다. 식이효율은 된장 샐러드 드레싱군이 대조군에 비해 유의적으로 낮았다(p<0.05). As shown in Table 8, there was no significant difference in dietary intake between the control group and the doenjang salad dressing group. The amount of feces was also higher in the doenjang salad dressing group, but no significant difference was recognized. Dietary efficiency was significantly lower in the doenjang salad dressing group than in the control group (p <0.05).
5) 혈청 중 생화학적 성분 및 각 조직의 무게 분석5) Biochemical component in serum and weight analysis of each tissue
(1) 시료 채취(1) sampling
상기 4)의 실험 종료 후 12시간 동안 절식시킨 실험동물을 에틸에테르로 마취시켰다. 마취 상태에서 개복한 즉시 심장에서 혈액을 채취하였으며 채취한 혈액을 실온에서 20분간 방치한 후 3,000rpm에서 15분 동안 원심 분리하여 혈청을 분리하였다. 분리한 혈청은 -70℃에서 냉동 보관한 후 분석에 사용하였다. 각 장기는 채혈 직후 즉시 적출하여 0.9% 생리 식염수로 헹구어 여과지(Whatman No. 2)로 물기를 제거한 후 중량을 측정하였다.Experimental animals fasted for 12 hours after the end of experiment 4) were anesthetized with ethyl ether. Blood was collected from the heart immediately after opening in anesthesia and the collected blood was left at room temperature for 20 minutes and then centrifuged at 3,000 rpm for 15 minutes to separate serum. The separated serum was stored frozen at -70 ℃ and used for analysis. Each organ was extracted immediately after blood collection, rinsed with 0.9% saline solution, drained with filter paper (Whatman No. 2), and weighed.
(2) 혈청 중의 생화학적 성분 분석(2) Analysis of Biochemical Components in Serum
총 지질(total lipid), 총 콜레스테롤(total cholesterol), HDL-콜레스테롤, LDL-콜레스테롤 농도는 효소 Kit(영동제약) 시약법에 의해 분광광도계(Model 80-2088-64, Pharmacia Biotech. Co., Cambridge, England)을 이용하여 505nm에서 흡광도를 측정하고, 하기 수학식 1에 의해 동맥경화지수(AI: Atherogenic Index)를 계산하여 표 9에 개시하였다.Total lipid, total cholesterol, HDL-cholesterol, LDL-cholesterol concentrations were measured by spectrophotometer (Model 80-2088-64, Pharmacia Biotech. Co., Cambridge) by enzyme kit , England) was used to measure the absorbance at 505 nm, and the atherosclerotic index (AI: Atherogenic Index) was calculated by
혈액중 총콜레스테롤, 중성지질, LDL콜레스테롤 농도는 된장샐러드 드레싱군이 대조군에 비해 유의적으로 낮았으며, 동맥경화지수(AI)도 낮게 나타나 동맥경화예방에 효과가 있는 것으로 나타났다.The total cholesterol, triglyceride, and LDL cholesterol levels in the blood were significantly lower in the doenjang salad dressing group than in the control group, and the arteriosclerosis index (AI) was also lower, indicating that it was effective in preventing atherosclerosis.
(3) 장기의 무게(3) weight of organs
실험동물의 무게 100g 당 간, 심장 및 신장의 평균 무게는 표 10과 같았다. 모든 조직의 무게는 대조군과 된장샐러드드레싱 투여군 간에 유의적인 차이가 없었다.The average weight of liver, heart and kidney per 100 g weight of the experimental animals was shown in Table 10. The weight of all tissues was not significantly different between the control group and the doenjang salad dressing group.
(4) 부위별 지방 조직의 무게(4) weight of adipose tissue by site
실험동물의 복강 뒤, 복강 내, 고환주위, 허벅지, 비장주위의 지방 무게(g/체중)를 측정하여 표 11에 나타내었다. 복강 뒤, 복강 내, 고환주위의 지방무게는 대조군과 드레싱 투여군간에 차이가 있었고, 허벅지, 비장주위의 지방 무게는 유의적인 차이는 없었다. 전체적인 지방 조직의 무게는 대조군에 비해 된장 샐러드 드레싱군이 유의적으로 낮았다(p<0.05). 복부지방 함량 및 총지방함량은 성인병 특히 동맥경화증 유발과 관련이 높다. After the abdominal cavity of the experimental animals, intraperitoneal, testicular periphery, thighs, spleen periphery fat weight (g / body weight) was measured and shown in Table 11. After the abdominal cavity, intraperitoneal and peri testicular fat weights were different between the control group and the dressing group, and there were no significant differences in the fat weights around the thigh and spleen. The total adipose tissue weight was significantly lower in the doenjang salad dressing group than in the control group (p <0.05). Abdominal fat content and total fat content are associated with the induction of adult disease, especially atherosclerosis.
6) 항산화 지표 분석6) Antioxidant Indicator Analysis
(1) 지질 과산화물 측정(1) lipid peroxide measurement
상기 5)에서 채취한 간조직에서 지질과산화물의 지표인 TBARS를 측정하여 표 12에 개시하였다. 지질과산화물은 thiobarbituric acid(TBA)방법(Bidlack & Tappel 1973)을 이용하여 생성된 malondialdehyde(MDA) 양을 533 nm에서 흡광도를 측정하였으며, tetramethoxypropane (malonaldehyde bis, TMP)를 표준물질로 사용하였다. 조직은 조직무게의 9배의 0.01M Sodium phosphate buffer(pH 7.4)와 혼합하여 균질한 후 사용하였다. 먼저 균질액의 200㎕에 8.1% SDS 용액 200㎕, 20% acetic acid 400㎕을 넣고 마지막에 0.75% TBA 용액 200㎕을 첨가하여 90℃에서 30분간 중탕한 후 10min동안 얼음에 넣어 냉각시켰다. 2400rpm에서 20분간 원심분리한 후 상층액을 분리하여 533nm에서의 흡광도를 측정하였다. blank는 D.W를 사용하였다.Table 12 shows TBARS, an indicator of lipid peroxide, in liver tissue collected in 5). Lipid peroxide was measured for absorbance at 533 nm by using thiobarbituric acid (TBA) method (Bidlack & Tappel 1973) and tetramethoxypropane (malonaldehyde bis, TMP) was used as a standard. Tissue was used after homogenizing with 9 times 0.01M sodium phosphate buffer (pH 7.4) of the tissue weight. First, 200 μl of 8.1% SDS solution and 400 μl of 20% acetic acid were added to 200 μl of homogenate, and finally, 200 μl of 0.75% TBA solution was added thereto, followed by water bath at 90 ° C. for 30 minutes, and then cooled on ice for 10 min. After centrifugation at 2400 rpm for 20 minutes, the supernatant was separated and the absorbance at 533 nm was measured. blank uses D.W.
된장 샐러드 드레싱군은 간, 혈장, 뇌, 신장, 심장조직 모두에서 대조군에 비하여 유의적으로 낮아졌다. 된장 샐러드 드레싱군은 대조군에 비하여 유의적으로 낮았다(p<0.05). 이는 대조군에 비하여 각 조직에서의 지질 과산화가 20-35% 억제된 것이다. Doenjang salad dressing group was significantly lower in liver, plasma, brain, kidney and heart tissue than in the control group. The doenjang salad dressing group was significantly lower than the control group (p <0.05). This is a 20-35% inhibition of lipid peroxidation in each tissue compared to the control.
(2) 항산화효소 활성도 측정(2) measurement of antioxidant enzyme activity
시토졸(Cytosol) 분획은 실험동물의 적혈구와 간조직을 Bansal 등의 방법(Bansal et al. Biochem. Biophys. Res Commun (1983) 117: 268-274)에 따라서 130 mM KCl을 함유한 30 mM HEPES buffer(pH 7.4)에 균질화시켜서 얻었으며, -70℃ 냉장고에 보관하면서 효소 활성을 측정하여 그 결과를 표 13에 기재하였다. Cytosol fractions were used to determine the erythrocytes and liver tissues of experimental animals by 30 mM HEPES containing 130 mM KCl according to Bansal et al. (Bansal et al. Biochem. Biophys. Obtained by homogenization in buffer (pH 7.4), the enzyme activity was measured while storing in a -70 ℃ refrigerator and the results are shown in Table 13.
항산화 효소 활성은 간 및 뇌조직의 GP(Glutathione peroxidase), GST(glutathione S-transferase)활성도를 측정하여 비교하였다. 간 및 뇌 조직에서의 항산화효소인 Glutathione peroxidase 활성을 유의적으로 높여주었으며, 항발암해독효소인 GST활성을 대조군에 비하여 간조직에서는 1.75배 뇌조직에서는 1.45배 증가시켰다. Antioxidant enzyme activity was compared by measuring GP (glutathione peroxidase) and GST (glutathione S-transferase) activity in liver and brain tissue. The activity of Glutathione peroxidase, an antioxidant enzyme in liver and brain tissues, was significantly increased, and the anti-cancer detoxifying enzyme, GST activity, was 1.75 times higher in liver tissue and 1.45 times higher in brain tissue than control group.
7) 혈액의 DNA의 7) DNA of blood 손상정도Damage
Mice 혈액 중 DNA 손상정도를 측정하기 위해 alkalin single-cell gel electrophoresis(comet assay)를 실시하였다. Slide에 0.5% Normal melting agarose(NMA)를 50 ㎕와 75 ㎕로 2번 코팅한 후 전혈 5 ㎕와 0.75% Low melting agarose(LMA) 75 ㎕의 현탄액을 골고루 분산시킨 후 cover glass로 덮어 4℃의 냉장온도에 저장하였다. Gel이 굳으면 그 위에 0.75% LMA 75 ㎕를 도포하여 한겹 더 코팅하였다. 미리 차게 준비해두었던 pH 10 lysis buffer에 DMSO와 TritionX-100을 섞은 시약에 slide를 담그어 한시간 동안 암실에 보관하면서 lysis 과정을 거쳤다. Lysis 과정을 끝낸 slide는 electrophoresis buffer에 40분에 저장하였다가 electrophoresis chamber에 배열하고 25V, 300mA에서 20분 동안 unwinding 시켰다. 전기영동이 끝난 slide는 pH 7.5 tris buffer에 5분씩 3회 세척하고 마지막으로 에탄올에 5분 담갔다가 말렸다.Mice Alkali single-cell gel electrophoresis (comet assay) was performed to measure the degree of DNA damage in blood. Apply 0.5% Normal melting agarose (NMA) to the slide twice with 50 μl and 75 μl twice, and then distribute the suspension with 5 μl of whole blood and 75 μl of 0.75% Low melting agarose (LMA) evenly. Stored at refrigeration temperature. When the gel was hardened, 75 μl of 0.75% LMA was applied thereon to further coat the gel. The slide was immersed in a reagent mixture of DMSO and TritionX-100 in
Comet image 분석을 하기 위해 ethidium bromide(20 ㎕/㎖)로 상기 방법으로 전기 영동한 nucleotide를 염색하여 형광현미경에서 관찰하고 카메라를 통해 comet image analyzing system이 설치된 컴퓨터에서 분석하였다. DNA 손상정도는 핵으로부터 이동한 DNA 파편의 거리(tail length, TL), tail 내 함유된 DNA% (tail DNA%) 그리고 TL값에 tail DNA를 곱해준 tail moment(TM) 값을 측정하였다(Wim et al. Life Sci. 2001 61: 1237-1244).In order to perform comet image analysis, nucleotides electrophoresed with ethidium bromide (20 μl / ml) were stained by fluorescence microscopy and analyzed on a computer equipped with a comet image analyzing system through a camera. DNA damage was measured by measuring the tail length (TL) of the DNA fragments moved from the nucleus, the DNA content (tail DNA%) in the tail, and the tail moment (TM) value multiplied by the tail DNA (Wim). et al. Life Sci. 2001 61: 1237-1244).
고지방 식이를 통한 된장 샐러드 드레싱의 급여로 인한 mouse 전혈의 DNA 손상정도를 tail DNA(TD), tail length(TL), olive tail moment(OTM)를 분석하여 하기 표 14에 나타내었다.DNA damage of mouse whole blood due to diet of miso salad dressing through high fat diet was analyzed by tail DNA (TD), tail length (TL) and olive tail moment (OTM).
Tail DNA(%)는 대조군이 9.72%인데 비하여 된장 샐러드 드레싱군은 5.54%로 유의적으로 낮았으며, tail length와 olive tail moment 역시 대조군이 7.95 μm와 1.15 된장 샐러드 드레싱군이 1.15 μm와 0.77로 유의적으로 적게 나타났는데(p<0.05), 이는 DNA의 손상이 적게 일어났기 때문이다. 따라서 된장 샐러드 드레싱이 혈액중의 DNA 보호 작용을 하는 것으로 해석되어진다.Tail DNA (%) was significantly lower (5.54%) in the doenjang salad dressing group, compared to 9.72% in the control group, and tail length and olive tail moment were also 1.15 μm and 0.77 in the 7.95 μm and 1.15 doenjang dressing groups. It was less likely (p <0.05) because of less damage to DNA. Thus, miso salad dressings are interpreted to protect DNA in the blood.
이상, 상기 실시예를 통하여 설명한 바와 같이, 본 발명 맛과 기능성이 우수한 된장을 함유한 된장 샐러드 드레싱 및 이의 제조방법은 마요네즈에 비해 열량이 적은 된장을 샐러드 드레싱에 첨가함으로써 샐러드 섭취 시 가장 많이 애용되는 마요네즈보다 열량과 지방함량이 낮으므로 비만과 그로 인한 퇴행성 질환의 예방에 유용하며, in- vivo 동물실험을 통해 확인하였듯이 혈액에서의 총콜레스테롤 농도 저하, 총중성지질농도 저하 및 동맥경화지수의 감소로 동맥경화예방에 효과를 나타내었다. 또한, 간 , 심장, 혈액, 신장 및 뇌조직에서의 항산화효과와 혈액 임파구의 DNA 손상을 방지하는 효과가 있으므로 산화적 손상에 의해 유발되는 노화를 비롯한 각종 질병 즉, 동맥경화, 암 등의 예방에 매우 뛰어난 효과가 있으므로 식품산업상 매우 유용한 발명인 것이다.As described above, as described through the above examples, the present invention has a taste and functionality of miso salad dressing containing miso and its manufacturing method is most favored during salad intake by adding miso calorie to salad dressing compared to mayonnaise mayonnaise with more calories and fat content is low, and therefore useful in the prevention of obesity and consequent degenerative diseases, in- vivo as confirmed by animal experiments decreased the total cholesterol concentration in the blood, decreasing total triglyceride and atherogenic index decreased It was effective in preventing atherosclerosis. In addition, it has an antioxidant effect on liver, heart, blood, kidney, and brain tissues and prevents DNA damage of blood lymphocytes, and thus prevents various diseases including aging caused by oxidative damage, such as arteriosclerosis and cancer. It is a very useful invention in the food industry because it has a very good effect.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060054093A KR20070119451A (en) | 2006-06-15 | 2006-06-15 | Composition of low calori soybean paste salad dressing with antioxidant and antiatherogenic activities and a preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060054093A KR20070119451A (en) | 2006-06-15 | 2006-06-15 | Composition of low calori soybean paste salad dressing with antioxidant and antiatherogenic activities and a preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20070119451A true KR20070119451A (en) | 2007-12-20 |
Family
ID=39137778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060054093A KR20070119451A (en) | 2006-06-15 | 2006-06-15 | Composition of low calori soybean paste salad dressing with antioxidant and antiatherogenic activities and a preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20070119451A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101423115B1 (en) * | 2013-01-22 | 2014-07-25 | 전북대학교산학협력단 | Method for producing salad dressing using Cheonggukjang with reduced Bacillus cereus |
CN104286818A (en) * | 2014-08-21 | 2015-01-21 | 山东省农业科学院农业质量标准与检测技术研究所 | Zasiokaurin-containing salad sauce and preparation method thereof |
-
2006
- 2006-06-15 KR KR1020060054093A patent/KR20070119451A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101423115B1 (en) * | 2013-01-22 | 2014-07-25 | 전북대학교산학협력단 | Method for producing salad dressing using Cheonggukjang with reduced Bacillus cereus |
CN104286818A (en) * | 2014-08-21 | 2015-01-21 | 山东省农业科学院农业质量标准与检测技术研究所 | Zasiokaurin-containing salad sauce and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wahrburg et al. | Mediterranean diet, olive oil and health | |
Acosta-Estrada et al. | Benefits and challenges in the incorporation of insects in food products | |
Hassan et al. | Production of functional biscuits for lowering blood lipids. | |
McMurry et al. | Dietary cholesterol and the plasma lipids and lipoproteins in the Tarahumara Indians: a people habituated to a low cholesterol diet after weaning | |
Punita et al. | Effect of feeding crude red palm oil (Elaeis guineensis) and grain amaranth (Amaranthus paniculatus) to hens on total lipids, cholesterol, PUFA levels and acceptability of eggs | |
Rhee et al. | Sensory properties and lipid oxidation in aerobically refrigerated cooked ground goat meat | |
Odebode et al. | Nutritional composition, antidiabetic and antilipidemic potentials of flour blends made from unripe plantain, soybean cake, and rice bran | |
Polmann et al. | Non-conventional nuts: An overview of reported composition and bioactivity and new approaches for its consumption and valorization of co-products | |
Akinbule et al. | Fatty acid, lipid profiles, and health lipid quality of selected Nigerian composite meals and soups | |
KR20070119451A (en) | Composition of low calori soybean paste salad dressing with antioxidant and antiatherogenic activities and a preparation method thereof | |
KR102221954B1 (en) | High Protein Healthy Cookies Using Meat and Method of Manufacturing the Same | |
KR100680185B1 (en) | Coposition of salad vegetables showing antioxidant activity | |
KR100732210B1 (en) | Composition of salad vegetables showing antiatherosclerotic activity | |
Lapsley et al. | Health benefits of almonds | |
Pal | Black rice-an extensive review | |
Reggiani et al. | Effects of physical activity and diet on lipemic risk factors for atherosclerosis in women | |
KR20070009208A (en) | A baek-kimchi having anti-obesity effect and a method for preparing the same | |
EP1045640A1 (en) | Crisp fried in grapeseed oil | |
KR20160080341A (en) | Manufacturing Method of Black Garlic Kimchi Sauce Hamburg Steak | |
Johnson Gottesfeld | The role of plant foods in traditional Wet'suwet'en nutrition | |
Kahlon | The New Food Guide Pyramid: Recommendations on Grains, Fruits, and Vegetables1 | |
Das et al. | Nutrient composition of some nuts and oilseeds based recipes of Assam, India | |
Meena et al. | Review article on Viruddha Ahara | |
Saharan et al. | DEVELOPMENT OF VALUE ADDED NAMAK PARE | |
Taiwo et al. | Proximate, mineral compositions and sensory evaluation of peanut burgers incorporated with vegetables |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20080521 Effective date: 20090422 |